These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15691541)

  • 41. Modeling and analysis of a within-host HIV/HTLV-I co-infection.
    Elaiw AM; AlShamrani NH
    Bol Soc Mat Mex; 2021; 27(2):38. PubMed ID: 33814640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mathematical analysis of the global dynamics of a model for HTLV-I infection and ATL progression.
    Wang L; Li MY; Kirschner D
    Math Biosci; 2002; 179(2):207-17. PubMed ID: 12208616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the infection system of human T-cell leukaemia virus type I based on a mathematical epidemic model.
    Eshima N; Tabata M; Kikuchi H; Karukaya S; Taguchi T
    Stat Med; 2001 Dec; 20(24):3891-900. PubMed ID: 11782041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Analysis of CD4+CD25+ T cells in transgenic rats carrying the env-pX gene of HTLV-I].
    Higuchi M
    Hokkaido Igaku Zasshi; 2002 Jul; 77(4):325-31. PubMed ID: 12187828
    [No Abstract]   [Full Text] [Related]  

  • 45. Dynamics of human T-cell lymphotropic virus I (HTLV-I) infection of CD4+ T-cells.
    Katri P; Ruan S
    C R Biol; 2004 Nov; 327(11):1009-16. PubMed ID: 15628223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability of HTLV/HIV dual infection model with mitosis and latency.
    Elaiw AM; AlShamrani NH
    Math Biosci Eng; 2021 Jan; 18(2):1077-1120. PubMed ID: 33757177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose Metabolism and Oxygen Availability Govern Reactivation of the Latent Human Retrovirus HTLV-1.
    Kulkarni A; Mateus M; Thinnes CC; McCullagh JS; Schofield CJ; Taylor GP; Bangham CRM
    Cell Chem Biol; 2017 Nov; 24(11):1377-1387.e3. PubMed ID: 28965728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro.
    Macchi B; Balestrieri E; Mastino A
    J Antimicrob Chemother; 2003 Jun; 51(6):1327-30. PubMed ID: 12716774
    [No Abstract]   [Full Text] [Related]  

  • 49. Evolutionary dynamics of HTLV-I.
    Wodarz D; Bangham CR
    J Mol Evol; 2000 May; 50(5):448-55. PubMed ID: 10824088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of an HTLV/HIV dual infection model with diffusion.
    Elaiw AM; AlShamrani NH
    Math Biosci Eng; 2021 Oct; 18(6):9430-9473. PubMed ID: 34814353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Backward bifurcation in within-host HIV models.
    Xie X; Ma J; van den Driessche P
    Math Biosci; 2021 May; 335():108569. PubMed ID: 33636199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What we are learning on HTLV-1 pathogenesis from animal models.
    Dodon MD; Villaudy J; Gazzolo L; Haines R; Lairmore M
    Front Microbiol; 2012; 3():320. PubMed ID: 22969759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Revisiting the extracellular lifestyle.
    Dumenil G
    Cell Microbiol; 2011 Aug; 13(8):1114-21. PubMed ID: 21615665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mother-to-Child Transmission of Human T-Cell Lymphotropic Viruses-1/2: What We Know, and What Are the Gaps in Understanding and Preventing This Route of Infection.
    Carneiro-Proietti AB; Amaranto-Damasio MS; Leal-Horiguchi CF; Bastos RH; Seabra-Freitas G; Borowiak DR; Ribeiro MA; Proietti FA; Ferreira AS; Martins ML
    J Pediatric Infect Dis Soc; 2014 Sep; 3 Suppl 1(Suppl 1):S24-9. PubMed ID: 25232474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discordance in the morphologic diagnosis of lymphocytes in HTLV-1-infected individuals.
    Fuji S; Muta M; Ikeda E; Sakai R; Hagiwara Y; Zaizen K; Makiyama J; Choi I; Takano K; Koh KR; Ishikawa J
    Int J Lab Hematol; 2022 Oct; 44(5):e250-e252. PubMed ID: 35702819
    [No Abstract]   [Full Text] [Related]  

  • 56. Dynamics of HIV-1/HTLV-I Co-Infection Model with Humoral Immunity and Cellular Infection.
    AlShamrani NH; Alshaikh MA; Elaiw AM; Hattaf K
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability of an HTLV-HIV coinfection model with multiple delays and CTL-mediated immunity.
    AlShamrani NH
    Adv Differ Equ; 2021; 2021(1):270. PubMed ID: 34054935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global Properties of Latent Virus Dynamics Models with Immune Impairment and Two Routes of Infection.
    Raezah AA; Elaiw AM; Alofi BS
    High Throughput; 2019 Jun; 8(2):. PubMed ID: 31163653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Backward bifurcations, turning points and rich dynamics in simple disease models.
    Zhang W; Wahl LM; Yu P
    J Math Biol; 2016 Oct; 73(4):947-76. PubMed ID: 26921202
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.